PEGylated liposome IHL-305 markedly improved the survival of ovarian cancer peritoneal metastasis in mouse
<p>Abstract</p> <p>Background</p> <p>Advanced ovarian cancer is characterized by peritoneal metastasis and the accumulation of ascites. Peritoneal metastasis of ovarian cancer is a major cause of the negative treatment outcome, as these metastases are resistant to most...
Main Authors: | Konishi Hiroaki, Takagi Akimitsu, Kurita Akinobu, Kaneda Norimasa, Matsuzaki Takeshi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/462 |
Similar Items
-
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors
by: Wu H, et al.
Published: (2015-02-01) -
Ultrasonography of peritoneal tuberculosis
by: Ababacar Mbengue, et al.
Published: (2019-06-01) -
Surgical tactics with acute pancreatitis complicated ascites-peritonitis
by: V. V. Kasian, et al.
Published: (2019-07-01) -
Factors affecting the pharmacokinetics and pharmacodynamics of PEGylated liposomal irinotecan (IHL-305) in patients with advanced solid tumors [Corrigendum]
by: Wu H, et al.
Published: (2019-07-01) -
Spontaneous Bacterial Peritonitis in Subclinical Hypothyroidism
by: Dalip Gupta, et al.
Published: (2013-11-01)